Trial intelligence / Profile preview

Phase I Safety Study of DCC-2618 in Heavily Pretreated GIST

jRCT2031260153Phase 1Recruiting

Sponsor

Ono Pharmaceutical

Start

Jul 2026

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1